AI Article Synopsis

  • - There are currently no established guidelines for determining the optimal size for augmented datasets to enhance model performance in machine learning.
  • - This paper introduces an automation pipeline that uses generative adversarial networks (GAN) to find the best data augmentation multiple, which significantly improves diagnostic performance based on a limited dataset of radiographs from chronic sinusitis patients.
  • - The proposed deep learning method can aid radiologists in making better diagnoses and offers a solution for researchers and industry professionals facing challenges with insufficient training data by leveraging synthetic data augmentation.

Article Abstract

Thus far, there have been no reported specific rules for systematically determining the appropriate augmented sample size to optimize model performance when conducting data augmentation. In this paper, we report on the feasibility of synthetic data augmentation using generative adversarial networks (GAN) by proposing an automation pipeline to find the optimal multiple of data augmentation to achieve the best deep learning-based diagnostic performance in a limited dataset. We used Waters' view radiographs for patients diagnosed with chronic sinusitis to demonstrate the method developed herein. We demonstrate that our approach produces significantly better diagnostic performance parameters than models trained using conventional data augmentation. The deep learning method proposed in this study could be implemented to assist radiologists in improving their diagnosis. Researchers and industry workers could overcome the lack of training data by employing our proposed automation pipeline approach in GAN-based synthetic data augmentation. This is anticipated to provide new means to overcome the shortage of graphic data for algorithm training.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9613909PMC
http://dx.doi.org/10.1038/s41598-022-22222-zDOI Listing

Publication Analysis

Top Keywords

data augmentation
20
diagnostic performance
12
generative adversarial
8
synthetic data
8
automation pipeline
8
data
7
augmentation
5
automation generative
4
adversarial network-based
4
network-based synthetic
4

Similar Publications

As the occurrence of human diseases and conditions increase, questions continue to arise about their linkages to chemical exposure, especially for per-and polyfluoroalkyl substances (PFAS). Currently, many chemicals of concern have limited experimental information available for their use in analytical assessments. Here, we aim to increase this knowledge by providing the scientific community with multidimensional characteristics for 175 PFAS and their resulting 281 ion types.

View Article and Find Full Text PDF

Genetic variation in IL-4 activated tissue resident macrophages determines strain-specific synergistic responses to LPS epigenetically.

Nat Commun

January 2025

Type 2 Immunity Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA.

How macrophages in the tissue environment integrate multiple stimuli depends on the genetic background of the host, but this is still poorly understood. We investigate IL-4 activation of male C57BL/6 and BALB/c strain specific in vivo tissue-resident macrophages (TRMs) from the peritoneal cavity. C57BL/6 TRMs are more transcriptionally responsive to IL-4 stimulation, with induced genes associated with more super enhancers, induced enhancers, and topologically associating domains (TAD) boundaries.

View Article and Find Full Text PDF

Revumenib: a new era in acute leukemia treatment.

Trends Cancer

January 2025

Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY, USA. Electronic address:

The AUGMENT-101 clinical trial reported that the use of revumenib led to improved overall survival (OS) and complete remission (CR)/CR with partial hematologic recovery (CRh) in patients with acute leukemias and has released updated data with longer follow-up of Phase 2 results. Additionally, revumenib has received FDA approval for its use in relapsed or refractory (r/r) lysine methyltransferase 2A rearranged (KMT2A-r) acute leukemias.

View Article and Find Full Text PDF

Eccentric Reaming is Superior to Augmented Components in B2 Glenoids: a Biomechanical study.

J Shoulder Elbow Surg

January 2025

Division of Orthopaedic Surgery, The Ottawa Hospital, University of Ottawa, Ottawa, ON, Canada. Electronic address:

Introduction: Primary glenohumeral arthritis is typically associated with glenoid retroversion and posterior bone loss. Glenoid component fixation remains a weak link in the survivorship of anatomical total shoulder arthroplasty, particularly in the B2 glenoid. The aim of this study was to compare biomechanical properties of two glenoid preparation techniques in a B2 glenoid bone loss model.

View Article and Find Full Text PDF

Background: Methylglyoxal (MGO), a highly reactive precursor of advanced glycation end products (AGEs), is endogenously produced and prevalent in various ultra-processed foods. MGO has emerged as a significant precursor implicated in the pathogenesis of type 2 diabetes and neurodegenerative diseases. To date, the effects of dietary MGO on the intestine have been limited explored.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!